SCHEMBL30833111

SCHEMBL30833111

Clc1cnc(C2CCOCC2)c(N2CCNCC2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 4/20 0.43
FAAH O00519 2/20 0.42
CHRNB2 P17787 2/20 0.41
CHRNA4 P43681 2/20 0.41
CCNC P24863 3/20 0.40
CDK8 P49336 3/20 0.40
ADRB2 P07550 1/20 0.39
NCF1 P14598 1/20 0.39
HTR3A P46098 3/20 0.38
CHRNA1 P02708 1/20 0.38
CHRNA7 P36544 1/20 0.38
HTR3E A5X5Y0 1/20 0.38
HTR3B O95264 1/20 0.38
HTR3D Q70Z44 1/20 0.38
HTR3C Q8WXA8 1/20 0.38
PIM1 P11309 1/20 0.37
HTR1A P08908 2/20 0.36
HTR2A P28223 2/20 0.36
HTR7 P34969 2/20 0.36
HTR2B P41595 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30833122 0.75 MAPT (0.47)
SCHEMBL31536999 0.68 HTR3E (0.56) HRH4CHRNB2CHRNA4NCF1HTR3A
SCHEMBL24312145 0.67 MAPT (0.45) NCF1
SCHEMBL4420245 0.66 ADRB1 (0.53) NCF1HTR3AHTR3EHTR3BHTR3D
SCHEMBL19145912 0.65 MAPT (0.42) NCF1
SCHEMBL30366123 0.65 TLR9 (0.40) FAAHHTR1AHTR6HTR2C
SCHEMBL26088142 0.65 MAPT (0.42)
SCHEMBL1736748 0.64 CHRNB2 (0.53) HRH4CHRNB2CHRNA4ADRB2CHRNA1
SCHEMBL5466686 0.63 CHRNB2 (0.51) HRH4CHRNB2CHRNA4ADRB2CHRNA1
SCHEMBL24312437 0.63 RAF1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4587432-A1 M4 ACTIVATORS/MODULATORS AND USES THEREOF Cerevel Therapeutics, LLC (US) 2025-07-23 EP disclosed
WO-2024059249-A1 M4 ACTIVATORS/MODULATORS AND USES THEREOF CEREVEL THERAPEUTICS, LLC (US) 2024-03-21 WO disclosed